Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gabapentin.

G L Morris1

  • 1Department of Neurology, Medical College of Wisconsin, Milwaukee, USA.

Epilepsia
|October 26, 1999
PubMed
Summary
This summary is machine-generated.

Gabapentin (GBP) effectively treats partial seizures in patients 12 and older. Higher doses may increase efficacy, with some studies suggesting doses above labeling are well tolerated and beneficial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Milk production of cows grazing pasture supplemented with grain mixes containing canola meal or corn grain or both over the first 100 days of lactation.

Journal of dairy science·2024
Same author

Influence of proportion of wheat in a pasture-based diet on milk yield, methane emissions, methane yield, and ruminal protozoa of dairy cows.

Journal of dairy science·2019
Same author

Effect of dietary fat supplementation on methane emissions from dairy cows fed wheat or corn.

Journal of dairy science·2019
Same author

Adaptation responses in milk fat yield and methane emissions of dairy cows when wheat was included in their diet for 16 weeks.

Journal of dairy science·2018
Same author

Influence of feeding supplements of almond hulls and ensiled citrus pulp on the milk production, milk composition, and methane emissions of dairy cows.

Journal of dairy science·2018
Same author

Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery.

Neurology·2003
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Gabapentin (GBP) is an antiepileptic drug structurally related to GABA.
  • Its precise mechanism of action in treating seizures remains unknown.
  • GBP readily crosses the blood-brain barrier and binds to CNS areas involved in seizure control.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of Gabapentin (GBP) in treating partial seizures.
  • To explore the effects of varying GBP dosages, including those exceeding standard labeling.

Main Methods:

  • Review of open-label and double-blind studies, including add-on and monotherapy trials.
  • Dose-ranging studies and comparisons with placebo and carbamazepine.
  • Analysis of responder rates (RR), seizure freedom rates, and adverse experiences.

Related Experiment Videos

Main Results:

  • Add-on therapy showed responder rates (RR) up to 28% in double-blind trials and 71% in open-label studies.
  • Higher doses (e.g., 1,800 mg to 3,600 mg) demonstrated progressively greater seizure reduction and freedom rates.
  • Monotherapy trials indicated improved study completion and time to exit with higher doses (3,600 mg vs. 300 mg).
  • Pediatric studies showed promising RR in refractory partial seizures.
  • Common adverse events included somnolence, dizziness, and ataxia; behavioral changes were noted in children.

Conclusions:

  • Gabapentin (GBP) efficacy increases with higher doses, potentially exceeding those in standard labeling.
  • Initiating therapy at higher doses (2,400 mg or 3,600 mg) may be well-tolerated and associated with increased efficacy.
  • GBP is a viable treatment option for partial seizures, particularly when optimized at higher dosage ranges.